e-learning
resources
Berlin 2001
Sunday 23.09.2001
Physiological and disease-related changes in lung cells
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cell-specific expression of peroxiredoxins in human lung and pulmonary sarcoidosis
V. L Kinnula, S. Lehtonen, R. Kaarteenaho-Wiik, E. Lakari, P. Paakko, S. W. Kang, S. G. Rhee, Y. Soini (Oulu, Finland; Bethesda, United States Of America)
Source:
Annual Congress 2001 - Physiological and disease-related changes in lung cells
Session:
Physiological and disease-related changes in lung cells
Session type:
Thematic Poster Session
Number:
572
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. L Kinnula, S. Lehtonen, R. Kaarteenaho-Wiik, E. Lakari, P. Paakko, S. W. Kang, S. G. Rhee, Y. Soini (Oulu, Finland; Bethesda, United States Of America). Cell-specific expression of peroxiredoxins in human lung and pulmonary sarcoidosis. Eur Respir J 2001; 16: Suppl. 31, 572
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Expression of redox-related selenoprotein P in lung tissues and fibroblasts obtained from the patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 825s
Year: 2006
Chemokine mRNA expression profiling in pulmonary sarcoidosis
Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis
Year: 2008
Beryllium-induced lung disease exhibits expression profiles similar to sarcoidosis
Source: Eur Respir J 2016; 47:1797-1808
Year: 2016
Decreased mRNA and protein expression of peroxiredoxin (PRDX6) in the COPD lung
Source: Eur Respir J 2004; 24: Suppl. 48, 320s
Year: 2004
Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010
Differential expression of telomerase activity in patients with autoimmune pulmonary fibrosis in BALF
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010
Distinct gene expression profiles of cultured stromal cells from the patients with idiopathic pulmonary fibrosis and lung adenocarcinoma
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
Distinct forms of BARD1 expressed in lung fibrosis and lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 325s
Year: 2006
Alterations of the expression pattern of aquaporin-1 (AQP1) in lungs from patients with diverse pulmonary diseases
Source: Annual Congress 2009 - Cell biology of lung disease
Year: 2009
Bromodomain inhibitor JQ1 attenuates TGF-beta-suppressed
SOD2
expression and reduces proliferation in human primary pulmonary fibroblasts
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
MiRNA expression profile is altered upon cystic fibrosis pulmonary exacerbation
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019
Differential expression of heme oxygenase (HO)-1 in macrophages of lung tumour and tumour-free lung tissues
Source: Annual Congress 2004 - Lung development and cancer
Year: 2004
Differential expression of IL-33 and HMGB1 in the lungs of stable cystic fibrosis patients
Source: Eur Respir J 2014; 44: 802-805
Year: 2014
Altered kinetics of TGFβ receptor II expression in pulmonary fibroblasts of COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 224s
Year: 2005
Expression and cell specific localization of glutathione-S-transferase omega in healthy human lung and COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 339s
Year: 2006
Reduced expression of CD44 on lung macrophages from patients with COPD
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
Pulmonary gene expression of tenascin-C and fibronectin in chronic obtructive pulmonary disease (COPD)
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012
microRNA profiling in pulmonary fibroblasts in COPD
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011
Altered expression of CuZn-SOD and thioredoxin correlate with the histopathological features in small airways of patients with severe COPD
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015
High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 454s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept